#Regulatory Approval

Pfizer's Lyme Vaccine Faces Regulatory Challenges Amid Promising Results

Recent findings on Pfizer's Lyme disease vaccine indicate potential efficacy but highlight significant regulatory hurdles ahead, with implications for drug supply chains.